F. Gordin

发表

American Thoracic Society Documents An Official ATS Statement : Hepatotoxicity of Antituberculosis Therapy

T. Sterling, J. Jereb, S. Schenker, 2006 .

CD4+ count-guided interruption of antiretroviral treatment.

J Darbyshire, N Clumeck, J Hoy, 2006, The New England journal of medicine.

The Impad of Human Immunodeficiency Virus Infedion on Drug-resistant Tuberculosis

W. El-Sadr, F. Gordin, C. Besch, 1996 .

An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Robert Horsburgh, Steven M Holland, S. Holland, 2007, American journal of respiratory and critical care medicine.

Rates of tuberculosis infection in healthcare workers providing services to HIV-infected populations. Terry Beirn Community Programs for Clinical Research on AIDS.

W. El-Sadr, F. Gordin, J. Matts, 1998, Infection control and hospital epidemiology.

Why START? Reflections that led to the conduct of this large long‐term strategic HIV trial

J. Lundgren, J. Neaton, S. Emery, 2015, HIV medicine.

Three months of rifapentine and isoniazid for latent tuberculosis infection.

J. Hackman, R. Chaisson, M. Conde, 2011, The New England journal of medicine.

Nontuberculous mycobacterial infections.

A. French, F. Gordin, D. Benator, 1997, The Medical clinics of North America.

Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS.

R. Chaisson, A. LaMarca, F. Siegal, 1993, The New England journal of medicine.

Pneumonia in HIV-infected persons: increased risk with cigarette smoking and treatment interruption.

P. Easterbrook, J. Lundgren, M. Roediger, 2008, American journal of respiratory and critical care medicine.

Tuberculosis control. Back to the future?

F. Gordin, 1992, JAMA.

Evaluating a Decade of Exposures to Blood and Body Fluids in an Inner-City Teaching Hospital

F. Gordin, Amy M Treakle, M. Schultz, 2011, Infection Control & Hospital Epidemiology.

Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome.

J. Mills, G. Simon, F. Gordin, 1984, Annals of internal medicine.

A randomized, placebo-controlled study of rifabutin added to a regimen of clarithromycin and ethambutol for treatment of disseminated infection with Mycobacterium avium complex.

C. Horsburgh, S. Shafran, D. Cohn, 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Early manifestations of disseminated Mycobacterium avium complex disease: a prospective evaluation.

C. Horsburgh, D. Cohn, F. Gordin, 1997, The Journal of infectious diseases.

Efficacy of rifabutin in the treatment of disseminated infection due to Mycobacterium avium complex. The Rifabutin Treatment Group.

F. Gordin, P. Sullam, B. Wynne, 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Nosocomial outbreak of respiratory tract colonization with Mycobacterium fortuitum: demonstration of the usefulness of pulsed-field gel electrophoresis in an epidemiologic investigation.

R. Wallace,, Yansheng Zhang, C. Gibert, 1991, The American review of respiratory disease.

Mycobacterium szulgai infection of the lung: case report and review of an unusual pathogen.

F. Gordin, D. Benator, V. Kan, 1997, The American journal of the medical sciences.

Rifapentine for the treatment of tuberculosis: is it all it can be?

F. Gordin, 2004, American journal of respiratory and critical care medicine.

USA300 methicillin-resistant Staphylococcus aureus bacteremia and the risk of severe sepsis: is USA300 methicillin-resistant Staphylococcus aureus associated with more severe infections?

O. C. Stine, M. Shardell, E. Perencevich, 2011, Diagnostic microbiology and infectious disease.

USA300 Methicillin-Resistant Staphylococcus aureus Bacteremia and the Risk of Severe Sepsis: Is USA300 MRSA Associated with More Severe Infections?

O. Stine, E. Perencevich, A. Lesse, 2011 .

Disseminated Mycobacterium fortuitum successfully treated with combination therapy including ciprofloxacin.

F. Gordin, P. Rohatgi, R. Rosenthal, 1990, The American review of respiratory disease.

Antimicrobial activity of rifabutin. Discussion

R. Chaisson, P. Philips, F. Gordin, 1996 .

The validity of acid-fast smears in the diagnosis of pulmonary tuberculosis.

G. Slutkin, F. Gordin, 1990, Archives of pathology & laboratory medicine.

Discontinuation of prophylaxis against Mycobacterium avium complex disease in HIV-infected patients who have a response to antiretroviral therapy. Terry Beirn Community Programs for Clinical Research on AIDS.

B. Gallagher, W. El-Sadr, A. Martínez, 2000, The New England journal of medicine.

Prophylaxis of Mycobacterium avium complex bacteremia in patients with AIDS.

H. Masur, F. Gordin, 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Simpliying large trials: An example from the community programs for clinical research on aids

F. Gordin, J. Matts, J. Korvick, 1992 .

The clinical pharmacokinetics of rifabutin. Discussion

R. Chaisson, T. Blaschke, F. Gordin, 1996 .

Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection

E. Hershfield, R. O'brien, L. Geiter, 2013, Pediatric Clinical Practice Guidelines & Policies.

Delayed diagnosis of pulmonary tuberculosis in city hospitals.

L. Sacks, F. Gordin, R. Sall, 1994, Archives of internal medicine.

Changing Clinician Practices and Attitudes Regarding the Use of Antiretroviral Therapy for HIV Treatment and Prevention

B. Branson, W. El-Sadr, K. Buchacz, 2017, Journal of the International Association of Providers of AIDS Care.

INSIGHT FLU005: An Anti-Influenza Virus Hyperimmune Intravenous Immunoglobulin Pilot Study.

R. Dewar, J. Metcalf, R. Davey, 2016, The Journal of infectious diseases.

Mycobacterium avium Complex

C. Horsburgh, F. Gordin, 2015 .

Predictors of bacterial pneumonia in Evaluation of Subcutaneous Interleukin‐2 in a Randomized International Trial (ESPRIT)

D. Cooper, E. Lin, S. Emery, 2011, HIV medicine.

Presumptive diagnosis and treatment of pulmonary tuberculosis based on radiographic findings.

P. Hopewell, G. Slutkin, P. Goodman, 1989, The American review of respiratory disease.

Considerations in the rationale, design and methods of the Strategic Timing of AntiRetroviral Treatment (START) study

A. Phillips, J. Lundgren, J. Neaton, 2013, Clinical trials.

The impact of human immunodeficiency virus infection on drug-resistant tuberculosis.

W. El-Sadr, J. Sampson, D. Cohn, 1996, American journal of respiratory and critical care medicine.

Panel on Clinical Practices for Treatment of HIV Infection

John W. Mellors, Martin Delaney, Robert T. Schooley, 2000 .

Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents, January 28, 2000

J. J. Henning, John G. Bartlett, Martin Delaney, 1998, HIV clinical trials.

Prevalence of human immunodeficiency virus and hepatitis B virus in unselected hospital admissions: implications for mandatory testing and universal precautions.

C. Gibert, F. Gordin, A. Willoughby, 1990, The Journal of infectious diseases.

Spontaneous pneumothorax with Pneumocystis carinii infection. Occurrence in patients with acquired immunodeficiency syndrome.

R. H. Parker, F. Gordin, L. Joe, 1986, Archives of internal medicine.

Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial

R. Chaisson, B. Metchock, A. Vernon, 2002, The Lancet.

Rates of Tuberculosis Infection in Healthcare Workers Providing Services to HIV-Infected Populations

W. El-Sadr, Elizabeth B Finley, F. Gordin, 1998, Infection Control & Hospital Epidemiology.

Cigarette Smoking: A Modifier of Human Immunodeficiency Virus Type 1 Infection?

J. Goedert, D. Fuchs, R. Biggar, 1991, Journal of acquired immune deficiency syndromes.

An outbreak of postoperative gram-negative bacterial endophthalmitis associated with contaminated trypan blue ophthalmic solution.

M. Arduino, A. Srinivasan, A. Labriola, 2009, Clinical Infectious Diseases.

Nontuberculous mycobacteria in patients with human immunodeficiency virus infection.

F. Gordin, D. Benator, 1996, Seminars in respiratory infections.

Efﬁcacy Testing of Recombinant Human Immunodeﬁciency Virus (HIV) gp160 as a Therapeutic Vaccine in Early-Stage HIV-1–Infected Volunteers

R. Redfield, C. Tacket, D. Birx, 2022 .

Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa

Michael I. Jordan, Donald A. Jackson, J. G. Ndirangu, 2016, Journal of the International AIDS Society.

Lessons learned: Infrastructure development and financial management for large, publicly funded, international trials

M. Vjecha, F. Hudson, Cate Carey, 2016, Clinical trials.

Inside-Out: The Changing Epidemiology of Methicillin-Resistant Staphylococcus aureus

F. Gordin, M. Schultz, J. Gill, 2010, Infection Control & Hospital Epidemiology.

Effect of subspecialty training and experience on agreement with HIV guidelines

C. R. Horsburgh, F. Gordin, S. Schaier, 1997, Journal of General Internal Medicine.

Use of ciprofloxacin for successful eradication of bacteremia due to Campylobacter cinaedi in a human immunodeficiency virus-infected person.

A. Labriola, V. Gill, L. Sacks, 1991, Reviews of infectious diseases.

Knowledge of AIDS among hospital workers: behavioral correlates and consequences.

L. Gurel, F. Gordin, L. Levine, 1987, AIDS.

Benefit of Early versus Deferred Antiretroviral Therapy on Progression of Liver Fibrosis among People with HIV in the START Randomized Trial

S. Emery, C. Stephan, A. Arenas-Pinto, 2019, Hepatology.

The Use of Tetanus Toxoid to Elucidate the Delayed-Type Hypersensitivity Response in an Older, Immunized Population

A. French, F. Gordin, M. E. Mccullough, 1997, Gerontology.

Hepatotoxicity of rifampin and pyrazinamide in the treatment of latent tuberculosis infection in HIV-infected persons: is it different than in HIV-uninfected persons?

R. Chaisson, R. O'brien, D. Cohn, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Increased Indoleamine-2,3-Dioxygenase Activity Is Associated With Poor Clinical Outcome in Adults Hospitalized With Influenza in the INSIGHT FLU003Plus Study

T. Griffin, R. Dewar, J. Metcalf, 2017, Open forum infectious diseases.

Evaluation of a third sequential tuberculin skin test in a chronic care population.

E. Perez-stable, P. Hopewell, G. Slutkin, 1988, The American review of respiratory disease.

Comparison of the Outcomes of Individuals With Medically Attended Influenza A and B Virus Infections Enrolled in 2 International Cohort Studies Over a 6-Year Period: 2009–2015

R. Schooley, E. Maltezos, Tak-chiu Wu, 2017, Open forum infectious diseases.

Pyogenic psoas abscesses: noninvasive diagnostic techniques and review of the literature.

F. Gordin, J. Mills, C. Stamler, 1983, Reviews of infectious diseases.

A controlled trial of early versus late treatment with zidovudine in symptomatic human immunodeficiency virus infection. Results of the Veterans Affairs Cooperative Study.

G L Drusano, S. Zolla-Pazner, P. Hartigan, 1992, The New England journal of medicine.

Aerosol pentamidine prophylaxis following Pneumocystis carinii pneumonia in AIDS patients: results of a blinded dose-comparison study using an ultrasonic nebulizer.

H. Waskin, M. Saag, R. Murphy, 1991, The American journal of medicine.

Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.

H. Lane, D. Cooper, A. Phillips, 2015, The New England journal of medicine.

Activities of pefloxacin and ciprofloxacin in experimentally induced Pseudomonas pneumonia in neutropenic guinea pigs

M. Sande, F. Gordin, C. Hackbarth, 1985, Antimicrobial Agents and Chemotherapy.

Amdinocillin therapy of experimental animal infections.

M. Sande, F. Gordin, 1983, The American journal of medicine.

Bacterial Contamination of Computer Keyboards in a Teaching Hospital

F. Gordin, Maureen Schultz, Janet Gill, 2003, Infection Control & Hospital Epidemiology.

Four Cases of Endophthalmitis Due to Trypan Blue

A. Labriola, F. Gordin, M. Carroll, 2009 .

Guidelines for preventing opportunistic infections among HIV-infected persons - 2002

Keiji Fukuda, Mark A. Jacobson, Cynthia L. Sears, 2002 .

Intravenous and oral ciprofloxacin in the therapy of serious infections.

M. Smith, C. Gibert, F. Gordin, 1990, Diagnostic microbiology and infectious disease.

Severe pancreatitis in an AIDS patient in association with cytomegalovirus infection.

F. Gordin, A. Ansher, L. Joe, 1989, Southern medical journal.

Interleukin-2 therapy in patients with HIV infection.

H. Lane, D. Cooper, A. Phillips, 2009, The New England journal of medicine.

Results of 117 esophageal replacements.

F. Gordin, M. Huguier, J. Lortat-Jacob, 1970, Surgery, gynecology & obstetrics.

A Large‐scale, Rapid Public Health Response to Rabies in an Organ Recipient and the Previously Undiagnosed Organ Donor

Carl J. Williams, J. Blanton, L. Finelli, 2014, Zoonoses and public health.

Evaluation of combination chemotherapy in a lightly anesthetized animal model of Pseudomonas pneumonia

M. Sande, F. Gordin, M. Rusnak, 1987, Antimicrobial Agents and Chemotherapy.

Biomarkers and Bacterial Pneumonia Risk in Patients with Treated HIV Infection: A Case-Control Study

S. Emery, B. Angus, J. Baker, 2013, PLoS ONE.

Risk assessment for healthcare workers after a sentinel case of rabies and review of the literature.

F. Gordin, D. Benator, G. Giannakos, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Financial Incentives for Linkage to Care and Viral Suppression Among HIV-Positive Patients

B. Branson, W. El-Sadr, L. Torian, 2017, JAMA internal medicine.

Effect of immediate initiation of antiretroviral therapy on risk of severe bacterial infections in HIV-positive people with CD4 cell counts of more than 500 cells per μL: secondary outcome results from a randomised controlled trial

D. Cooper, A. Phillips, J. Lundgren, 2017, The lancet. HIV.

Three months of weekly rifapentine and isoniazid for treatment of Mycobacterium tuberculosis infection in HIV-coinfected persons

R. Chaisson, J. Miro, T. Sterling, 2016, AIDS.

When to start antiretroviral therapy: the need for an evidence base during early HIV infection

J. Lundgren, J. Neaton, A. Babiker, 2013, BMC Medicine.

Immunodeficiency and the risk of serious clinical endpoints in a well studied cohort of treated HIV-infected patients

D. Cooper, J. Neaton, M. Law, 2010, AIDS.

Cigarette smoking, bacterial pneumonia, and other clinical outcomes in HIV-1 infection. Terry Beirn Community Programs for Clinical Research on AIDS.

J. Neaton, R. Sherer, F. Gordin, 1996, Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology.

Is frequent CD4+ T-lymphocyte count monitoring necessary for persons with counts >=300 cells/μL and HIV-1 suppression?

A. Labriola, F. Gordin, H. Hoffman, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Long-term follow-up of symptomatic HIV-infected patients originally randomized to early versus later zidovudine treatment: Report of a Veterans Affairs Cooperative Study

P. Hartigan, W. O'brien, G. Drusano, 1996 .

Reduction in Nosocomial Transmission of Drug-Resistant Bacteria After Introduction of an Alcohol-Based Handrub

F. Gordin, M. Schultz, J. Gill, 2005, Infection Control & Hospital Epidemiology.

A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS.

W. El-Sadr, R. Hafner, F. Gordin, 1997, The New England journal of medicine.

Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trial.

J. Lundgren, J. Neaton, B. Grund, 2018, The lancet. HIV.

Progress Realized: Trends in HIV-1 Viral Load and CD4 Cell Count in a Tertiary-Care Center from 1999 through 2011

A. Labriola, F. Gordin, H. Hoffman, 2013, PloS one.

Illicit Drug Use and Risk for USA300 Methicillin-Resistant Staphylococcus aureus Infections with Bacteremia

M. Shardell, E. Perencevich, A. Lesse, 2010, Emerging infectious diseases.

Assessment of the 48-Hour Rule for Identifying Community-Associated Methicillin-Resistant Staphylococcus aureus Infection Complicated by Bacteremia

M. Shardell, E. Perencevich, A. Lesse, 2010, Infection Control & Hospital Epidemiology.

Two-stage tuberculin skin testing in individuals with human immunodeficiency virus infection

C. Salveson, K. Muth, F. Gordin, 1995 .

Geographic and seasonal variation in Mycobacterium avium bacteremia among North American patients with AIDS.

C. Horsburgh, D. Cohn, F. Gordin, 1997, The American journal of the medical sciences.

Efficacy testing of recombinant human immunodeficiency virus (HIV) gp160 as a therapeutic vaccine in early-stage HIV-1-infected volunteers. rgp160 Phase II Vaccine Investigators.

R. Redfield, C. Tacket, D. Birx, 2000, The Journal of infectious diseases.

Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial

R. Schooley, R. Dewar, J. Metcalf, 2019, The Lancet. Respiratory medicine.

Defining optimal treatment for recurrent Clostridioides difficile infection (OpTION study): A randomized, double-blind comparison of three antibiotic regimens for patients with a first or second recurrence.

D. Reda, R. Ringer, C. Donskey, 2022, Contemporary Clinical Trials.

Stability of positive tuberculin tests: are boosted reactions valid?

E. Perez-stable, P. Hopewell, G. Schecter, 1991, The American review of respiratory disease.

Current approaches to tuberculosis in the United States.

H. Masur, F. Gordin, 2012, JAMA.

The association between symptoms and microbiologically defined response to tuberculosis treatment.

John L. Johnson, Craig M. Hales, R. Chaisson, 2013, Annals of the American Thoracic Society.

Assessing targeted screening and low rates of HIV testing.

F. Gordin, V. Kan, L. Kennedy, 2010, American journal of public health.

Once-daily ceftriaxone for skin and soft tissue infections

J. Mills, F. Gordin, C. Wofsy, 1985, Antimicrobial Agents and Chemotherapy.

Delayed-type hypersensitivity skin tests are an independent predictor of human immunodeficiency virus disease progression. Department of Veterans Affairs Cooperative Study Group.

S. Zolla-Pazner, P. Hartigan, N. Klimas, 1994, The Journal of infectious diseases.

Delayed-type hypersensitivity skin tests are an independent predictor of human immunodeficiency virus disease progression. Department of Veterans Affairs Cooperative Study Group.

S. Zolla-Pazner, P. Hartigan, N. Klimas, 1994, The Journal of infectious diseases.

Using Clinical Research Networks to Assess Severity of an Emerging Influenza Pandemic

Henrik Nielsen, L. Mathiesen, C. Leen, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Long-term follow-up of symptomatic HIV-infected patients originally randomized to early versus later zidovudine treatment; report of a Veterans Affairs Cooperative Study. VA Cooperative Study Group on AIDS Treatment.

P. Hartigan, W. O'brien, G. Drusano, 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

A Cluster of Hemodialysis-Related Bacteremia Linked to Artificial Fingernails

F. Stock, F. Gordin, M. Schultz, 2007, Infection Control & Hospital Epidemiology.

Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America.

David R. Holtgrave, M. Alter, J. Phair, 2002, Annals of internal medicine.

Clostridium difficile colitis associated with trimethoprim-sulfamethoxazole given as prophylaxis for Pneumocystis carinii pneumonia.

F. Gordin, M. Schmidt, C. Gibert, 1994, The American journal of medicine.

Pneumoproteins and biomarkers of inflammation and coagulation do not predict rapid lung function decline in people living with HIV

T. Harrer, A. Winston, E. Harrer, 2023, Scientific Reports.

Title : Benefit of early versus deferred antiretroviral therapy on progression of liver fibrosis among people with HIV in the START randomized trial

S. Emery, C. Stephan, A. Arenas-Pinto, 2018 .